Clearside Biomedical earnings were -$30.8M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest CLSD earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$8.2M, up 12.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CLSD reported annual earnings of -$34.4M, with 5.7% growth.
Clearside Biomedical Earnings Reports & History FAQ
What were Clearside Biomedical's earnings last quarter?
On CLSD's earnings call on Invalid Date, Clearside Biomedical (NASDAQ: CLSD) reported Q1 2025 earnings per share (EPS) of -$0.11, up 35.29% year over year. Total CLSD earnings for the quarter were -$8.22 million. In the same quarter last year, Clearside Biomedical's earnings per share (EPS) was -$0.17.
Is Clearside Biomedical profitable or losing money?
As of the last Clearside Biomedical earnings report, Clearside Biomedical is currently losing money. Clearside Biomedical's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$30.81 million, a 11.89% decrease year over year.
What was CLSD's earnings growth in the past year?
As of Clearside Biomedical's earnings date in Invalid Date, Clearside Biomedical's earnings has grown year over year. CLSD earnings in the past year totalled -$30.81 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.